spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online February 6, 2009
doi: 10.1242/10.1242/dev.027565

Development 136, 865-875 (2009)
Published by The Company of Biologists 2009
This Article
Right arrow Summary Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matthews, R. P.
Right arrow Articles by Pack, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Matthews, R. P.
Right arrow Articles by Pack, M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

TNF{alpha}-dependent hepatic steatosis and liver degeneration caused by mutation of zebrafish s-adenosylhomocysteine hydrolase

Randolph P. Matthews1, Kristin Lorent2, Rafael Mañoral-Mobias2, Yuehua Huang3, Weilong Gong2, Ian V. J. Murray3, Ian A. Blair3 and Michael Pack2,4,*

1 Division of Gastroenterology, Hepatology, and Nutrition, The Children's Hospital of Philadelphia and Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
2 Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
3 Centers for Cancer Pharmacology and Excellence in Environmental Toxicology and University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
4 Department of Cell and Developmental Biology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.


Figure 1
View larger version (124K):
[in this window]
[in a new window]

  		Fig. 1. Hepatic steatosis and liver degeneration in dtp zebrafish larvae. (A-D) Lateral views of 5-dpf wild-type (wt, A,C) and dtp mutant (B,D) larvae showing small liver (outlined, arrow) and reduced yolk consumption (y) in dtp. (C,D) RNA in situ hybridization for the liver marker transferrin (tfa) demonstrates smaller liver size (arrow) in dtp. (E-J) Liver histology showing irregular dtp hepatoctye nuclei beginning at 3 dpf (compare F with E) and with cellular degeneration that is pronounced at 5 dpf (compare J with I). (K,L) Oil Red O (ORO) staining reveals neutral lipid in the small liver of a 5-dpf dtp larva (L) but not in the wild type (K). (M-P) Electron micrographs of the enlarged nuclei (compare N with M, arrowheads), mitochondrial defects (compare P with O, m) and lipid droplets (P, arrows) in 5-dpf dtp hepatocytes. c, canaliculus; eso,esophagus; liv, liver.

 

Figure 2
View larger version (30K):
[in this window]
[in a new window]

  		Fig. 2. Identification of ahcy as the dtp gene. (A) Schematic of the zebrafish dtp locus. The nearest polymorphic markers are indicated, with corresponding numbers of recombinants and calculated genetic distances. (B) Deduced amino acid sequence near the ahcy mutation identified in dtp larvae (indicated in red; DR, Danio rerio), with corresponding amino acid sequence of orthologous Ahcy proteins from Homo sapiens (HS), Xenopus laevis (XL), Drosophila melanogaster (DM) and Roseobacter. (C) Schematic of the methionine metabolism pathway. Reduced Ahcy activity is predicted to increase levels of SAH, which inhibits methyltransferases. (D-G) ahcy expression in staged zebrafish embryos and larvae. Ubiquitous expression is evident through 24 hpf. Expression at 48 hpf and 72 hpf is restricted to the liver (yellow arrow), intestine (green arrow) and pancreas (blue arrow). (H) Immunostaining at sphere stage, showing ubiquitous immunoreactive Ahcy protein.

 

Figure 3
View larger version (32K):
[in this window]
[in a new window]

  		Fig. 3. Altered methionine and methyl metabolism in dtp larvae. (A) SAM and SAH levels, and (B) SAM:SAH ratio in wild-type (wt) and dtp zebrafish larvae. (C) SAM and SAH levels in 2-dpf wild-type and dtp embryos injected with control morpholino (dtp cont), and dtp embryos injected with either wild-type ahcy mRNA or mRNA carrying the ahcydtp missense mutation. ****P<0.00001, ***P<0.0001, **P<0.01, Figure 3P<0.05; NS, not significant (P=0.3). (D) Calculated SAM:SAH ratio for the four conditions in C. Differences in the SAM:SAH ratio between B and D arise from experimental variation. (E) Anti-methylcytosine ({alpha}MeC) slot blot of genomic DNA derived from wild-type or dtp larvae, with Methylene Blue counterstain (MeBl). (F) Western blot showing reduced levels of methylated lysine residues ({alpha}MeK) in protein from dtp larvae; actin provided a loading control ({alpha}actin).

 

Figure 4
View larger version (63K):
[in this window]
[in a new window]

  		Fig. 4. Increased expression of lipogenic and stress-responsive genes in dtp larvae, and rescue of dtp steatosis and liver degeneration with tnfa knockdown. (A-D) Expression levels of peroxisome proliferator-activated receptor gamma (pparg, A), sterol response element binding protein 1 (srebp1, B), glutathione peroxidase (gpx, C) and tumor necrosis factor alpha (tnfa, D) in 4-dpf dtp versus wild-type (wt) siblings. Inset for D shows Tnf{alpha} western blot in 5-dpf dtp larvae. *P<0.05, **P<0.005; NS, not significant (P=0.07). (E,F) Whole-mount RNA in situ hybridization showing enhanced tnfa expression in the liver (outlined), intestine (arrow) and swim bladder (*) of a dtp larva (F) as compared with a wild-type sibling (E). (G) Western blot showing reduced Tnf{alpha} protein in tnfa morpholino-injected larvae. (H) Lateral view of a fixed 5-dpf dtp larva injected with tnfa antisense morpholino oligonucleotide at 2 dpf; liver size is enlarged (outlined), compare with live dtp 5-dpf larva depicted in Fig. 1. (I) Liver rescue in tnfa morpholino-injected dtp mutant as revealed by transferrin (tfa) in situ hybridization. (J,K) tnfa knockdown also rescues dtp liver histology (compare with Fig. 1J). (L) Mitochondrial ultrastructure is improved and steatosis is rescued by tnfa knockdown. eso, esophagus; li, liver; m, mitochondria.

 

Figure 5
View larger version (46K):
[in this window]
[in a new window]

  		Fig. 5. Ahcy inhibition in adult zebrafish causes liver steatosis and activates tnfa expression. (A) Quantitative real-time PCR reveals elevated tnfa expression in adult zebrafish liver following 7-day treatment with the Ahcy inhibitor 3-deaza-adenosine (deazaA). (B,C) Oil Red O staining reveals steatosis in deazaA-treated adult livers, as compared with control. (D) Reduced liver mitochondrial glutathione (GSH) in deazaA-treated adult fish compared with control. *P<0.05, **P<0.005; error bars indicate s.e.m.

 

Figure 6
View larger version (63K):
[in this window]
[in a new window]

  		Fig. 6. Liver steatosis, increased lipogenic gene expression, and methionine metabolism defects in adult dtp heterozygotes. (A,B) SAM and SAH levels from livers of (A) adult fish treated with deazaA and (B) adult dtp heterozygotes, as compared with wild-type (wt) controls. (C,D) Liver histology from adult wild-type and heterozygous dtp fish showing vesicular clearing consistent with steatosis. (E,F) Oil Red O staining of adult wild-type and heterozygous dtp fish reveals steatosis in the heterozygotes. Lipid is evident in wild-type liver sinusoids (E, arrows), but not in hepatocytes. (G-I) Elevated expression of tnfa (G), pparg (H) and the ROS-sensitive gene thioredoxin reductase (trx) (I), in the liver of adult dtp heterozygous versus wild-type fish. *P=0.05, **P<0.05, ***P<0.005.

 

Figure 7
View larger version (13K):
[in this window]
[in a new window]

  		Fig. 7. Mechanistic model of hepatic steatosis and liver degeneration caused by Ahcy deficiency. Mutation of ahcy disrupts Ahcy activity, increasing cellular SAH. This alters mitochondrial function and reduces cellular methylation potential, thereby altering the expression of lipogenic genes such as tnfa and pparg, possibly through an epigenetic mechanism involving alteration of the histone methylation code. This leads to enhanced lipid synthesis, reduced lipid utilization and, possibly, enhanced lipid uptake, as well as to the sensitization of hepatocytes to TNF{alpha}-induced cell death. Additional, as yet unidentified effects of altered SAH or altered methylation potential might also play a mechanistic role in the dtp phenotype.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



© The Company of Biologists Ltd 2009